Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Cizzle Biotech (CIZ) Share Price

Price 1.50p on 22-04-2025 at 08:30:22
Change 0.00p 0%
Buy 1.60p
Sell 1.40p
Buy / Sell CIZ Shares
Last Trade: Sell 68,905.00 at 1.46p
Day's Volume: 68,905
Last Close: 1.50p
Open: 1.50p
ISIN: GB00BNG2VN02
Day's Range 1.50p - 1.50p
52wk Range: 1.40p - 2.65p
Market Capitalisation: £6m
VWAP: 1.46p
Shares in Issue: 396m

Cizzle Biotech (CIZ) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 68,905 1.46p Ordinary
09:25:58 - 22-Apr-25
Buy* 95,541 1.57p Ordinary
16:19:24 - 17-Apr-25
Buy* 250,000 1.57p Ordinary
15:49:25 - 17-Apr-25
Buy* 127,534 1.5199p Ordinary
14:32:55 - 17-Apr-25
Buy* 1,282 1.5199p Ordinary
14:29:24 - 17-Apr-25
Buy* 106,363 1.53p Ordinary
13:53:50 - 17-Apr-25
Buy* 15,481 1.53p Ordinary
13:46:05 - 17-Apr-25
Sell* 175,000 1.32p Ordinary
13:06:37 - 17-Apr-25
Buy* 25,000 1.54p Ordinary
13:06:25 - 17-Apr-25
Sell* 150,000 1.41p Ordinary
12:10:30 - 17-Apr-25
See more Cizzle Biotech trades

Cizzle Biotech (CIZ) Share Price History

Time period:
to
Date Open High Low Close Volume
21st Apr 2025 (Mon) 1.50 1.50 1.50 1.50 0
18th Apr 2025 (Fri) 1.50 1.50 1.50 1.50 0
17th Apr 2025 (Thu) 1.55 1.55 1.45 1.50 1,457,949
16th Apr 2025 (Wed) 1.55 1.55 1.55 1.55 0
15th Apr 2025 (Tue) 1.55 1.55 1.55 1.55 54,461
14th Apr 2025 (Mon) 1.55 1.55 1.55 1.55 350,727
11th Apr 2025 (Fri) 1.55 1.55 1.55 1.55 61,288
10th Apr 2025 (Thu) 1.55 1.55 1.55 1.55 454,301
9th Apr 2025 (Wed) 1.55 1.55 1.45 1.55 669,077
8th Apr 2025 (Tue) 1.55 1.55 1.55 1.55 132,483
7th Apr 2025 (Mon) 1.40 1.55 1.40 1.55 835,181
4th Apr 2025 (Fri) 1.50 1.50 1.40 1.40 312,062
3rd Apr 2025 (Thu) 1.40 1.50 1.40 1.50 1,381,894
2nd Apr 2025 (Wed) 1.55 1.55 1.45 1.50 953,854
1st Apr 2025 (Tue) 1.55 1.55 1.55 1.55 183,527
31st Mar 2025 (Mon) 1.65 1.65 1.50 1.55 440,825
28th Mar 2025 (Fri) 1.65 1.65 1.65 1.65 48,926
27th Mar 2025 (Thu) 1.50 1.65 1.50 1.65 307,896
26th Mar 2025 (Wed) 1.65 1.65 1.45 1.50 2,272,402
25th Mar 2025 (Tue) 1.65 1.65 1.65 1.65 267,000
24th Mar 2025 (Mon) 1.60 1.65 1.60 1.65 626,131
See more Cizzle Biotech price history

Cizzle Biotech (CIZ) Regulatory News

Date Source Headline
14th Apr 2025 10:00 am RNS-R Launch of New Website
25th Mar 2025 7:00 am RNS Appointment of Non-Executive Director
24th Mar 2025 7:00 am RNS Update on Launch of CIZ1B Biomarker Assay
2nd Jan 2025 7:00 am RNS Appointment of Professor Dawn Coverley as CSO
16th Dec 2024 7:00 am RNS Update on Strategic Partnership in North America
21st Oct 2024 7:00 am RNS Execution of Agreement for North America
3rd Oct 2024 1:12 pm RNS Update on Licensing and Partnership Agreement
30th Sep 2024 7:00 am RNS Interim Results
16th Sep 2024 7:00 am RNS Holding(s) in Company
9th Sep 2024 7:00 am RNS Collaboration with Moffitt Cancer Center
See more Cizzle Biotech regulatory news

Cizzle Biotech (CIZ) Share News

IN BRIEF: Cizzle Biotechnology appoints Founder Dawn Coverley as CSO

2nd Jan 2025 14:29

Cizzle Biotechnology Holdings PLC - London-based life sciences company engaged in developing a blood test for the early detection of the different forms of lung cancer - Appoints Founder & Non-Executive Director Dawn Coverley as chief scientific officer, effective immediately. Says the new role replaces her position as a NED and accelerates its global licensing and partnership strategy to bring its non-invasive, cost effective, CIZ1B biomarker lung cancer blood test to market in 2025. Read More

EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens

30th Sep 2024 18:37

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: Light Science Technologies wins two new contracts

9th Sep 2024 22:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

17th Jun 2024 15:53

Read More

Cizzle says CIZ1B biomarker test picked for "major" US cancer study

17th Jun 2024 13:33

(Alliance News) - Cizzle Biotechnology Holdings PLC on Monday announced that its proprietary test for the CIZ1B biomarker has been chosen as part of "an important clinical study" at a "leading" US cancer centre. Read More

See more Cizzle Biotech news
FTSE 100 Latest
Value8,296.22
Change20.56

Login to your account

Forgot Password?

Not Registered